Type 1 Diabetes
Conditions
Keywords
type 1 diabetes, intermitent continous glucose monitoring, Flash
Brief summary
Observational cross-sectional multicenter study about clinical effect of intermitent continuous glucose monitoring (Flash) in adult type 1 diabetes patients in an Spanish public health system.
Detailed description
Observational cross-sectional multicenter study about clinical effect of intermitent continuous glucose monitoring (Flash) in adult type 1 diabetes patients in an Spanish public health system. All clinical variables are gathered from chart review. Data analysis is conducted using SPSS statistic software. Results are presented as mean +/- SD values. A paired Student´s t-test or Wilconxon signed test were used fr the analysis differences. Comparison between proportions were analyzed using a chi-square test. A P value \<0.05 was considered statistically significant. The protocolo was apporved by the reference Castilla-La Mancha Public Health Service Ethic Commitee. All participants provided written consent.
Interventions
Use of the device FreeStyle Libre, only commercialized system for intermitent continuous glucose monitoring.
Sponsors
Study design
Eligibility
Inclusion criteria
* Presence of Type 1 diabetes. * Age \>18 years. * Patients previously followed in the DIACAM study.
Exclusion criteria
* Any other kinds of diabetes.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| HbA1c difference | 1 year | Difference in HbA1c before initiating iCGM compared with HbA1c levels after one year of treatment. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| %CV | 1 year | Percentage of the variation coefficient (%, \>36% is considered high levels) |
| Body weight | 1 year | Total corporal body weight (Kg) |
| Insulin dose | 1 year | Daily insulin dose requirements (UI/Kg/d) |
| TBR | 1 year | Time bellow range (TBR, \<3.9 mmol/L) of the interstitial glucose |
| TIR | 1 year | Time in range (TIR, 3.9-10 mmol/L) of the interstitial glucose |
| TAR | 1 year | Time above range (TAR, \>10 mmol/L) of the interstitial glucose |
| Frequency of SBGM | 1 year | Daily number of blood capilary test fot glycemia determination. |
| Adherence to Flash | 1 year | Time of use of Flash glucose monitoring (% possible time of use) |
Countries
Spain